1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Translational Grant is sponsored by V Foundation for Cancer Research. These grants support 'bench to bedside' research whose endpoint is often planning or initiation of a clinical trial. Translational projects should move a novel strategy from the laboratory to a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the funder's official program page to help you evaluate fit faster.
Cancer Research Grant Award Programs | V Foundation High Risk, High Reward: Why Bold Science Starts with Early-Stage Investigators “The Needle is Being Moved” “Meaningful, Impactful and Inspirational”: Dr. Jones on Donor Support Investigating Better Treatment Options for Breast Cancer Patients Diversity, Equity and Inclusion There are 5 different types of grants awarded by the V Foundation including V Scholar Grants, Translational Grants, Game-Changer Grants, Mission Grants and All-Star Grants, each varying in size and duration.
Because of highly competitive reviews, V Foundation grant recipients invariably have excellent reputations within the scientific community. Learn more about the grant selection process The V Scholar Grant is a four-year grant of $200,000 per year. The V Scholar Award supports tenure-track faculty early in their cancer research careers by funding projects that are either laboratory-based fundamental research or translational research.
For more information regarding V Scholar eligibility, please refer to the Researcher Resources . The Translational Grant is a four-year grant of $200,000 per year. These grants support “bench to bedside” research whose endpoint is often planning or initiation of a clinical trial.
Translational projects should move a novel strategy from the laboratory to a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The All-Star Grant is a re-investment in previous V Scholar, Translational, or Game-Changer (previously Designated) cancer research grant recipients who are invited to apply for a $1,000,000 grant payable over 5 years.
Type of cancer research funded is specific to the RFA. We are looking for the most innovative ideas to improve the cancer landscape for patients. This grant type supports basic or translational research.
These are special grant opportunities for applications that arise out of donor interest, fundraising events or special funding partnerships with other nonprofit or corporate partners. These grants are part of our Powered by the V grant portfolio. Mission grants are a smaller grant opportunities that support educational projects within the V Foundation’s focus to advance research processes.
These grants are part of our Powered by the V grant portfolio. View all types of cancer research funded by the V Foundation by visiting our Funded Grants page. You can search by grant type, the year the grant was awarded, or by the state of the cancer center that received the grant.
St.
Jude Children's Research Hospital Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Memorial Sloan Kettering Cancer Center Herbert Irving Comprehensive Cancer Center Stanford Cancer Institute University of Colorado Cancer Center Case Comprehensive Cancer Center Andrei Thomas-Tikhonenko, PhD Boston Children's Hospital University of Hawaii Cancer Center Mass General Brigham Cancer Institute OHSU Knight Cancer Institute/OHSU Memorial Sloan Kettering Cancer Center Moores Comprehensive Cancer Center/University of California, San Diego UNC Lineberger Comprehensive Cancer Center "The support from V Foundation was key for developing the new models.
This gives our lab a very unique tool that puts us in a priority position to carry out certain types of research." The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage {vendor_count} vendors The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors
According to the current listing, eligibility includes: Researchers conducting 'bench to bedside' translational cancer research. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000 per year for four years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Translational Grant are due December 2, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Translational Grant is funded by V Foundation for Cancer Research. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
RFA-RM-27-008 funds one or two U24 centers to sequence 6,000-10,000 pediatric samples a year for Gabriella Miller Kids First. Due January 8, 2027. Who can compete.
Read articleProp. 38, the $8.4 billion immunology research bond, led 56% to 44% the morning after the November 3, 2026 election. Here is what the statute says about who can get the grant money, the 20% indirect cap, and the timeline.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read article